Abstract
Direct pacing of the mid myocardium where re-entry originates can be used to prevent ventricular arrhythmias and circumvent the need for painful defibrillation or cardiac ablation. However, there are no pacing electrodes small enough to navigate the coronary veins that cross these culprit scar regions. To address this need, we have developed an injectable ionically conductive hydrogel electrode that can fill the epicardial coronary veins and transform them into flexible electrodes. A new hydrogel chemistry based on a polyether urethane diacrylamide macromer was developed that matches myocardial stiffness and is resistant to hydrolysis. Conductivity was imparted using ionic precursor solutions with values in the range of 2-3X of native myocardium that was retained after implantation. Ionic hydrogel electrodes provided stable electrical stimuli over many cycles and across a substantial length of the cardiac vein. Rapid in situ cure was achieved with redox initiation after injection from a double-barrel syringe with a mixing head. An ex vivo porcine model was used to identify the requisite viscosity and cure rate for hydrogel retention and homogeneity. Finally, successful in vivo deployment and pacing in a porcine model demonstrated that the ionic hydrogel electrode filled the anterior interventricular vein to depths far more distal and refined than current technologies. Collectively, these studies demonstrate the potential of this injectable ionic hydrogel electrode to pace previously inaccessible mid-myocardial tissue and pave the pathway for painless defibrillation.
| Original language | English |
|---|---|
| Article number | 123071 |
| Journal | Biomaterials |
| Volume | 317 |
| DOIs | |
| State | Published - Jun 2025 |
Bibliographical note
Publisher Copyright:© 2025 Elsevier Ltd
Funding
Funding was provided by the National Institutes of Health, grant number R01 HL162741 (ECH, MR), Ford Pre-Doctoral Fellowship, administered by the National Academy of Science, Engineering and Medicine (GJRR), Ford Dissertation Fellowship, administered by the National Academy of Science, Engineering and Medicine (GJRR), Office of Vice President for Research, The University of Texas at Austin (ECH), The Roderick D. MacDonald Research Fund Award 19RDM004 (MR), The Sultan Qaboos Chair in Cardiology at the St. Luke's Foundation (MR)The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Elizabeth Cosgriff-Hernandez reports financial support was provided by National Institutes of Health, grant number R01 HL162741. Gabriel Rodriguez-Rivera reports financial support was provided by Ford Foundation. Mehdi Razavi reports financial support was provided by The Roderick D. MacDonald Research Fund Award. Elizabeth Cosgriff-Hernandez reports a relationship with Rhythio Medical that includes: board membership and equity or stocks. Elizabeth Cosgriff-Hernandez has patent Electrically conductive hydrogels useable as pacemaker lead extensions, apparatus for delivery of a hydrogel into the venous system, and methods of treating ventricular arrhythmia with electrically conductive hydrogels injected in the venous system pending to Elizabeth Cosgriff-Hernandez, Mehdi Razavi, Allison Post. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Funding was provided by the National Institutes of Health, grant number R01 HL162741 (ECH, MR), Ford Pre-Doctoral Fellowship, administered by the National Academy of Science, Engineering and Medicine (GJRR), Ford Dissertation Fellowship, administered by the National Academy of Science, Engineering and Medicine (GJRR), Office of Vice President for Research, The University of Texas at Austin (ECH), The Roderick D. MacDonald Research Fund Award 19RDM004 (MR), The Sultan Qaboos Chair in Cardiology at the St. Luke’s Foundation (MR)
| Funders | Funder number |
|---|---|
| St. Luke's Foundation | |
| University of Texas at Austin | |
| Ford Foundation | |
| Office of the Executive Vice President for Research and Partnerships, Purdue University | |
| GJRR | |
| National Academy of Science, Engineering and Medicine | |
| National Institutes of Health (NIH) | R01 HL162741 |
| National Institutes of Health (NIH) | |
| ECH Engineering Ltd | 19RDM004 |
Keywords
- Arrhythmias
- Biomaterials
- Conductive
- Hydrogels
- Injectable
- Pacing
ASJC Scopus subject areas
- Biophysics
- Bioengineering
- Ceramics and Composites
- Biomaterials
- Mechanics of Materials